Article: Bradmer announces 2009 first quarter operational and financial results.

TSX: BMR

TORONTO, May 7 /PRNewswire-FirstCall/ -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") today announced its 2009 first quarter operational and financial results.

Operational Highlights

During the three months ended March 31, 2009, the Company commenced a strategic review of its operations, as more particularly described in news releases of the Company dated February 17, 2009, March 5, 2009, and March 31, 2009. Pursuant to the strategic review, the Company has closed its Phase III GLASS-ART Trial to further patient enrollment, as the completion of initial milestones was projected to fully exhaust the Company's cash ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!